Literature DB >> 19258022

Now or Later? An fMRI study of the effects of endogenous opioid blockade on a decision-making network.

Charlotte A Boettiger1, Elizabeth A Kelley, Jennifer M Mitchell, Mark D'Esposito, Howard L Fields.   

Abstract

Previously, we found that distinct brain areas predict individual selection bias in decisions between small immediate ("Now") and larger delayed rewards ("Later"). Furthermore, such selection bias can be manipulated by endogenous opioid blockade. To test whether blocking endogenous opioids with naltrexone (NTX) alters brain activity during decision-making in areas predicting individual bias, we compared fMRI BOLD signal correlated with Now versus Later decision-making after acute administration of NTX (50 mg) or placebo. We tested abstinent alcoholics and control subjects in a double-blind two-session design. We defined regions of interest (ROIs) centered on activation peaks predicting Now versus Later selection bias. NTX administration significantly increased BOLD signal during decision-making in the right lateral orbital gyrus ROI, an area where enhanced activity during decision-making predicts Later bias. Exploratory analyses identified additional loci where BOLD signal during decision-making was enhanced (left orbitofrontal cortex, left inferior temporal gyrus, and cerebellum) or reduced (right superior temporal pole) by NTX. Additional analyses identified sites, including the right lateral orbital gyrus, in which NTX effects on BOLD signal predicted NTX effects on selection bias. These data agree with opioid receptor expression in human frontal and temporal cortices, and suggest possible mechanisms of NTX's therapeutic effects.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19258022      PMCID: PMC2729462          DOI: 10.1016/j.pbb.2009.02.008

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  86 in total

1.  Effects of acute and chronic doses of naltrexone on ethanol self-administration in rhesus monkeys.

Authors:  A E Boyle; R B Stewart; M J Macenski; R Spiga; B A Johnson; R A Meisch
Journal:  Alcohol Clin Exp Res       Date:  1998-04       Impact factor: 3.455

2.  Three-dimensional MRI atlas of the human cerebellum in proportional stereotaxic space.

Authors:  J D Schmahmann; J Doyon; D McDonald; C Holmes; K Lavoie; A S Hurwitz; N Kabani; A Toga; A Evans; M Petrides
Journal:  Neuroimage       Date:  1999-09       Impact factor: 6.556

3.  A comparison of the effects of the opioid antagonists naltrexone, naltrindole, and beta-funaltrexamine on ethanol consumption in the rat.

Authors:  M F Stromberg; M Casale; L Volpicelli; J R Volpicelli; C P O'Brien
Journal:  Alcohol       Date:  1998-05       Impact factor: 2.405

4.  Gender and age influences on human brain mu-opioid receptor binding measured by PET.

Authors:  J K Zubieta; R F Dannals; J J Frost
Journal:  Am J Psychiatry       Date:  1999-06       Impact factor: 18.112

5.  Specific cognitive deficits in mild frontal variant frontotemporal dementia.

Authors:  S Rahman; B J Sahakian; J R Hodges; R D Rogers; T W Robbins
Journal:  Brain       Date:  1999-08       Impact factor: 13.501

6.  Naltrexone's effect on cue-elicited craving among alcoholics in treatment.

Authors:  P M Monti; D J Rohsenow; K E Hutchison; R M Swift; T I Mueller; S M Colby; R A Brown; S B Gulliver; A Gordon; D B Abrams
Journal:  Alcohol Clin Exp Res       Date:  1999-08       Impact factor: 3.455

7.  Non-specific effect of naltrexone on ethanol consumption in social drinkers.

Authors:  H de Wit; J Svenson; A York
Journal:  Psychopharmacology (Berl)       Date:  1999-09-01       Impact factor: 4.530

8.  Kappa2 opioid receptors in limbic areas of the human brain are upregulated by cocaine in fatal overdose victims.

Authors:  J K Staley; R B Rothman; K C Rice; J Partilla; D C Mash
Journal:  J Neurosci       Date:  1997-11-01       Impact factor: 6.167

9.  Effects of naltrexone on alcohol self-administration in heavy drinkers.

Authors:  D Davidson; T Palfai; C Bird; R Swift
Journal:  Alcohol Clin Exp Res       Date:  1999-02       Impact factor: 3.455

10.  Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction.

Authors:  C Bond; K S LaForge; M Tian; D Melia; S Zhang; L Borg; J Gong; J Schluger; J A Strong; S M Leal; J A Tischfield; M J Kreek; L Yu
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

View more
  31 in total

1.  Catechol-O-methyltransferase genotype modulates opioid release in decision circuitry.

Authors:  Jennifer M Mitchell; James P O'Neil; William J Jagust; Howard L Fields
Journal:  Clin Transl Sci       Date:  2013-06-13       Impact factor: 4.689

Review 2.  The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical review.

Authors:  Lara A Ray; Christina S Barr; Julie A Blendy; David Oslin; David Goldman; Raymond F Anton
Journal:  Alcohol Clin Exp Res       Date:  2011-09-06       Impact factor: 3.455

Review 3.  Pharmacogenetics of alcohol use disorder treatments: an update.

Authors:  Emily E Hartwell; Henry R Kranzler
Journal:  Expert Opin Drug Metab Toxicol       Date:  2019-06-11       Impact factor: 4.481

4.  An adaptive, individualized fMRI delay discounting procedure to increase flexibility and optimize scanner time.

Authors:  Mikhail N Koffarnus; Harshawardhan U Deshpande; Jonathan M Lisinski; Anders Eklund; Warren K Bickel; Stephen M LaConte
Journal:  Neuroimage       Date:  2017-08-10       Impact factor: 6.556

5.  Preliminary functional MRI results from a combined stop-signal alcohol-cue task.

Authors:  Hollis C Karoly; Barbara J Weiland; Amithrupa Sabbineni; Kent E Hutchison
Journal:  J Stud Alcohol Drugs       Date:  2014-07       Impact factor: 2.582

6.  Current insights into the mechanisms and development of treatments for heavy drinking cigarette smokers.

Authors:  Daniel J O Roche; Lara A Ray; Megan M Yardley; Andrea C King
Journal:  Curr Addict Rep       Date:  2016-02-03

Review 7.  The role of the orbitofrontal cortex in alcohol use, abuse, and dependence.

Authors:  David E Moorman
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2018-02-09       Impact factor: 5.067

8.  Interacting effects of naltrexone and OPRM1 and DAT1 variation on the neural response to alcohol cues.

Authors:  Joseph P Schacht; Raymond F Anton; Konstantin E Voronin; Patrick K Randall; Xingbao Li; Scott Henderson; Hugh Myrick
Journal:  Neuropsychopharmacology       Date:  2012-10-03       Impact factor: 7.853

9.  Effect of Victimization on Impulse Control and Binge Drinking among Serious Juvenile Offenders from Adolescence to Young Adulthood.

Authors:  Jordan P Davis; Tara M Dumas; Benjamin L Berey; Gabriel J Merrin; Joseph R Cimpian; Brent W Roberts
Journal:  J Youth Adolesc       Date:  2017-04-24

10.  Recurrent, robust and scalable patterns underlie human approach and avoidance.

Authors:  Byoung Woo Kim; David N Kennedy; Joseph Lehár; Myung Joo Lee; Anne J Blood; Sang Lee; Roy H Perlis; Jordan W Smoller; Robert Morris; Maurizio Fava; Hans C Breiter
Journal:  PLoS One       Date:  2010-05-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.